Acquired nucleic acid changes may trigger sporadic amyotrophic lateral sclerosis

Muscle and Nerve

Volumn 32, Issue 3, 2005, Pages 373-377

  Armon, Carmel ^a  

^a BAYSTATE MEDICAL CENTER   (United States)

Author keywords

ALS initiation; Cycad circinalis; DNA alkylation; Genetic environmental interactions; Nucleic acid changes; Smoking

Indexed keywords

CARCINOGEN; NEUROTOXIN; NUCLEIC ACID;

AGE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL FEATURE; CYCAD CIRCINALIS; CYCADOPHYTA; DISEASE COURSE; DNA ALKYLATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INCIDENCE; INGESTION; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

AMYOTROPHIC LATERAL SCLEROSIS; CAUSALITY; DNA DAMAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; NEUROTOXINS; NUCLEIC ACIDS; RISK FACTORS; SMOKING;

EID: 24144451080     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20372     Document Type: Article

References (40)

1. Agar J, Durham H. Relevance of oxidative injury in the pathogenesis of motor neuron diseases. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:232-242.
2. Al-Chalabi A, Andersen PM, Chioza B, Shaw C, Sham PC, Robberecht W, et al. Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common rounder: evidence for a linked protective factor. Hum Mol Genet 1998;7:2045-2050.
3. Andersen PM, Sims KR, Xin WW, Kiely R, O'Neill G, Ravits J, et al. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:62-73.
4. Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology 2003;22:217-228.
5. Armon C. Epidemiology of ALS/MND. In: Shaw P, Strong M, editors. Motor neuron disorders. Amsterdam: Elsevier; 2003. p 167-206.
6. Banack SA, Cox PA. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Neurology 2003;61:387-389.
7. Bradley WG, Krasin F. A new hypothesis of the etiology of amyotrophic lateral sclerosis. The DNA hypothesis. Arch Neurol 1982;39:677-680.
8. Caroscio JT, Mulvihill MN, Sterling R, Abrams B. Amyotrophic lateral sclerosis. Its natural history. Neurol Clin 1987;5: 1-8.
9. Cox PA, Banack SA. Murch SJ. Biomagnification of cyanobacterial neurotoxins and neurodegenenitive disease among the Chamorro people of Guam. Proc Natl Acad Sci USA 2003; 100:13380-13383.
10. Cox PA, Sacks OW. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Neurology 2002;58: 956-959.
11. Cudkowics ME, McKenna-Yasek D, Chen C, Hedley-Whyle KT, Brown RH Jr. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene. Ann Neurol 1998;43:703-710.
12. Esclaire F, Kisby G, Spencer P, Milne J, Lesort M, Hugon J. The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau mRNA expression and excitotoxicity. Exp Neurol 1999;155:11-21.
13. Figlewics DA, Orrell RW. The genetics of motor neuron diseases. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:225-231.
14. Glantz SA, Parmley WW. Passive smoking and heart disease. Mechanisms and risk. JAMA 1995;273:1047-1053.
15. Gompertz B. On the nature of the function expressive of the law of human mortality. Philos Trans R Soc London 1825;115: 513-585.
16. Hand CK, Rouleau GA. Familial amyotrophic lateral sclerosis. Muscle Nerve 2002;25:135-159.
17. Kamel F, Umbach OM, Munsat TL, Shefner JM, Sandler DP. Association of cigarette smoking with amyotrophic lateral sclerosis. Neuroepidemiology 1999;18:194-202.
18. Khabazian I, Bains JS, Williams DE, Cheung J, Wilson JM, Pasqualotto BA, et al. Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex. J Neurochem 2002;82:516-528.
19. Kisby GE, Kabel H, Hugon J, Spencer P. Damage and repair of nerve cell DNA in toxic stress. Drug Metab Rev 1999;31: 589-618.
20. Lavine L, Steele JC, Wolfe N, Calne DB, O'Brien PC, Williams DB, et al. Amyotrophic lateral sclerosis/parkinsonism-dementia complex in southern Guam: is it disappearing? Adv Neurol 1991;56:271-285.
21. Majoor-Krakaner D, Willems PJ, Hofman A. Genetic epidemiology of amyotrophic lateral sclerosis. Clin Genet 2003;63:83-101.
22. Murch SJ, Cox PA, Banack SA, Steele JC, Sacks OW. Occurrence of beta-methylamino-L-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol Scand 2004;110:267-269.
23. Nelson LM. Epidemiology of ALS. Clin Neurosci 1995;3:327-331.
24. Nelson LM, McGuire V, Longstreth WT Jr, Matkin C. Population-based case-control study of amyotrophic lateral sclerosis in Western Washington State. 1. Cigarette smoking and alcohol consumption. Am J Epidemiol 2000;151:156-163.
25. Nielson S, Robinson I, Hunter M. Longitudinal Gompertzian analysis of ALS mortality in England and Wales. 1963-1989: estimates of susceptibility in the general population. Mech Ageing Dev 1992;64:210-216.
26. Nogales-Gadea G, Garcia-Arumi E, Andren AL, Cervera C, Gamez J. A novel exon 5 mutation (N139H) in the SOD1 gene in a Spanish family associated with incomplete penetrance. J Neurol Sci 2004;219:1-6.
27. Papamichael C, Karatzis E, Karatzi K, Aznaouridis K, Papaioannou T, Protogerou A, Stamatelopoulos K, Zampelas A, et al. Red wine's antioxidants counteract acute endothelial dysfunction caused by cigarette smoking in healthy nonsmokers. Am Heart J 2004;147:E5.
28. Parton MJ, Broom W, Andersen PM, Al-Chalabi A, Leigh NP, Powell JF, et al. D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype. Hum Mutat 2002;20:473.
29. Phillips DH. Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 2002;23:1979-2004.
30. Pradas J, Finison L, Andres PL, Thornell B, Hollander D, Munsat TL. The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials. Neurology 1993;43:751-755.
31. Rieger R, Michaelis A, Green MM. Glossary of genetics: classical and molecular, 5th ed. Berlin: Springer; 1991.
32. Riggs JE. Longitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in the U.S., 1977-1986: evidence for an inherently susceptible population subset. Mech Ageing Dev 1990;55:207-220.
33. Roman GC. Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis. J Neurol Neurosurg Psychiatry 1996;61:131-137.
34. Sadiq SA, Latov N. Monoclonal gammopathy and motor neuron disease. Adv Neurol 1991;56:413-420.
35. Simpson EP, Yen AA, Appel SH. Oxidative stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis. Curr Opin Rheumatol 2003;15:730-736.
36. Spencer PS, Allen CN, Kisby GE, Ludolph AC, Ross SM, Roy DN. Lathyrism and Western Pacific amyotropbic lateral sclerosis: etiology of short and long latency motor system disorders. In: Rowland LP. editor. Advances in neurology. New York: Raven Press; 1991. p. 287-299.
37. Strong MJ, Hudson AJ, Alvord WG. Familial amyotrophic lateral sclerosis, 1850-1989: a statistical analysis of the world literature. Can J Neurol Sci 1991;18:45-58.
38. Suthers G, Laing N, Wilton S, Dorosz S, Waddy H. "Sporadic" motoneuron disease due to familial SOD1 mutation with low penetrance. Lancet 1994;344:1773.
39. Tandan R, Robison SH, Munzer JS, Bradley WG. Deficient DNA repair in amyotrophic lateral sclerosis cells. J Neurol Sci 1987;79:189-203.
40. Yang Y, Hentati A, Deng HX, Dabbagh O, Sasaki T, Hirano M, et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001;29: 160-165.